| Name | Title | Contact Details |
|---|---|---|
Heather Lowrie |
CISO | Profile |
demandDrive is the industry leader in sales development and demand generation. We provide clients with a full-service sales development function as well as data & demand generation programs to help them optimize their sales & marketing processes and increase revenue growth. demandDrive provides a dedicated team of Sales Development Reps and combines best practices in sales development and demand generation with industry-leading sales enablement tools to uncover and qualify new sales opportunities. demandDrive has become a pioneer in lead Generation, specializing in developing and executing custom sales / marketing programs for clients in the technology space. Services include, but are not limited to: - Integrated Inbound & Outbound Lead Generation - Startup Sales Acceleration - Data Services - Sales & Marketing Intelligence - Demand Generation Consulting demandDrive utilizes a consultative approach to kick-start lead generation and combines the flexibility of outsourcing with the expertise and continued development of a close-knit internal team. Dedicated Sales Development Reps are seasoned through an intensive dD Certification Program and work closely with clients sales and marketing teams to understand their product. This attention to detail allows for high volume, high quality and actionable sales opportunities. demandDrive has collected top honors such as being named to the Inc. 5000 list of fastest growing private companies in the US and being deemed one of the top 20 companies in the country for work-life balance (per Glassdoor).
Akron Auto Auction (AAA) provides wholesale used vehicle buyers and sellers a fast-paced auto auction marketplace focused on driving their business forward. Built on long lasting relationships, Akron Auto Auction prides itself on superior customer service and providing clients with a wide range of auto remarketing solutions for their every need. Each Tuesday, AAA hosts an auction of 1000 vehicles across 6 Lanes and on Simulcast, handling consignments from new and used car stores, banks, fleets, and government agencies. For more information, go to www.akronautoauction.com **********************************************************************************
Southern Bancorp is a certified Community Development Financial Institution (CDFI) and B-Corp based in Arkadelphia, Arkansas. Established in 1986, it aims to strengthen underserved communities through financial services and development programs. The organization has grown significantly, now managing assets between $2.6 and $2.8 billion and serving around 65,000 customers in Arkansas and Mississippi. Southern Bancorp operates through three main entities: Southern Bancorp Bank, which provides traditional banking services; Southern Bancorp Community Partners, a nonprofit focused on financial education and support; and Southern Bancorp Incorporated, a holding company for strategic growth. The organization offers a range of services, including checking and savings accounts, loans, financial literacy workshops, and grants for community projects. With 56 locations and a commitment to equitable access, Southern Bancorp emphasizes long-term community impact, particularly in economically distressed areas.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.